Who owns AZIYO BIOLOGICS INC?
- Ticker: ELUT
- CUSIP Number: 05479k106
Tip: Access positions for across all investors
Analyze quarterly positions in Aziyo Biologics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aziyo Biologics stock
Who bought or sold AZIYO BIOLOGICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Nantahala Capital Management | 3.2M | $3.1M | 0% | Jun 2026 |
|
| AIGH Capital Management | 2.7M | $2.6M | -25% | Jun 2026 |
|
| Knollwood Investment Advisory | 2.6M | $2.5M | 0% | Jun 2026 |
|
| Silverarc Capital Management | 2.2M | $2.1M | -12% | Jun 2026 |
|
| Vanguard Capital Management | 1.1M | $1.1M | 12% | Jun 2026 |
|
| Perkins Capital Management | 694k | $380k | -8% | Jun 2026 |
|
| Geode Capital Management | 285k | $279k | -3% | Jun 2026 |
|
| CI Private Wealth | 254k | $248k | 2% | Jun 2026 |
|
| Renaissance Technologies | 202k | $198k | 144% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 172k | $169k | 44% | Jun 2026 |
|
| BlackRock | 168k | $164k | 38% | Jun 2026 |
|
| Birchview Capital | 165k | $162k | 0% | Jun 2026 |
|
| Citadel Advisors | 124k | $121k | 10% | Jun 2026 |
|
| Rossmore Private Capital | 120k | $118k | 0% | Jun 2026 |
|
| GSA Capital Partners | 89k | $88k | 100% | Jun 2026 |
|
| XTX Topco | 53k | $52k | 38% | Jun 2026 |
|
| Jane Street | 45k | $44k | -30% | Jun 2026 |
|
| Northern Trust | 45k | $44k | 61% | Jun 2026 |
|
| Atom Investors | 44k | $43k | 100% | Jun 2026 |
|
| LRI Investments | 25k | $25k | 100% | Jun 2026 |
|
| Brown Advisory Holdings Incorporated | 20k | $20k | 0% | Jun 2026 |
|
| Verdence Capital Advisors | 19k | $19k | 0% | Jun 2026 |
|
| Qube Research & Technologies | 17k | $17k | 1% | Jun 2026 |
|
| Hardesty Capital Management Corp. | 15k | $14k | 0% | Jun 2026 |
|
| Fund Evaluation Group | 13k | $12k | 0% | Jun 2026 |
|
| Indie Asset Partners | 13k | $12k | 0% | Jun 2026 |
|
| State Street Corporation | 12k | $13k | 0% | Mar 2026 |
|
| Mercer Global Advisors | 12k | $11k | 100% | Jun 2026 |
|
| Virtu Financial | 11k | $11k | 100% | Jun 2026 |
|
| Family Management Corporation | 10k | $9.8k | 0% | Jun 2026 |
|
| Marathon Capital Management | 10k | $9.8k | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 8.1k | $8.0k | 0% | Jun 2026 |
|
| Morgan Stanley | 7.0k | $7.3k | -13% | Mar 2026 |
|
| Wells Fargo & Company | 5.0k | $4.9k | 0% | Jun 2026 |
|
| UBS Group | 1.1k | $1.1k | -85% | Jun 2026 |
|
| Tower Research Capital | 767.00 | $750.969700 | -83% | Jun 2026 |
|
| Barclays | 388.00 | $380.007200 | 100% | Jun 2026 |
|
| SBI Securities | 55.00 | $53.999000 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 1.00 | $1.000000 | 100% | Jun 2026 |
|
Who sold out of Aziyo Biologics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| FNY Investment Advisers | Mar 2026 | 45k | $46k |
| Arcus Capital Partners | Mar 2026 | 30k | $32k |
| Royal Bank of Canada | Mar 2026 | 242.00 | $0 |
| Bnp Paribas Arbitrage, Snc | Mar 2026 | 3.00 | $3.000000 |